The consideration amount is Rs211.25 Million i.e. Rs68 per share.
Effective from 1st December, 2016, JCB became subsidiary of the Company upon acquisition of 70% stake in JCB by the Company. With the additional acquisition of 15%, the shareholding of the Company in JCB will increase to 85%.
JCB is engaged in the business of manufacturing and sales of Bio Pharmaceuticals through the process of aerobic fermentation.
At around 10:03 AM, Advanced Enzyme Technologies was trading at Rs436.60 apiece down by Rs21.35 or 4.66% from its previous closing of Rs457.95 apiece on the BSE.